Shareholder Alert: The Ademi Firm investigates whether Repare Therapeutics Inc. is obtaining a Fair Price for its Public Shareholders
Provided By PR Newswire
Last update: Nov 15, 2025
MILWAUKEE, Nov. 14, 2025 /PRNewswire/ -- The Ademi Firm is investigating Repare (Nasdaq: RPTX) for possible breaches of fiduciary duty and other violations of law in its recently announced transaction with XenoTherapeutics, Inc.
Read more at prnewswire.com2.1
-0.05 (-2.33%)
Find more stocks in the Stock Screener
RPTX Latest News and Analysis
